NCT03846375 Emotional Dysregulation in Para-suicidal Behavior
| NCT ID | NCT03846375 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Haukeland University Hospital |
| Condition | Self Harm |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2019-01-15 |
| Primary Completion | 2025-01-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2019-01-15 with a primary completion date of 2025-01-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a naturalistic cohort pre-post study investigating aspects of emotional processing and how possible changes in emotional processing is related to the successful treatment of non-suicidal self-injury and suicidal ideation in a program of Dialectical Behavior Therapy. In addition we wish to identify to what extent the intensity and frequency of non-suicidal self-injury and suicidal ideation is related to difficulty in emotion regulation, as indicated by self-report measures and psychophysiological measures.
Eligibility Criteria
Inclusion Criteria Patients: * Patients with non-suicidal self-injury and/or suicidal ideation that undergo standard clinical outpatient DBT treatment will be recruited. Exclusion Criteria Patients: * Lack of informed consent Exclusion Criteria Healthy Controls: * Lack of informed consent * former or current neurological conditions * severe psychiatric illness * cardiac conditions.
Contact & Investigator
Berge Osnes, PhD
PRINCIPAL INVESTIGATOR
Haukeland University Hospital
Frequently Asked Questions
Who can join the NCT03846375 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Self Harm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03846375 currently recruiting?
Yes, NCT03846375 is actively recruiting participants. Contact the research team at berge.osnes@uib.no for enrollment information.
Where is the NCT03846375 trial being conducted?
This trial is being conducted at Bergen, Norway.
Who is sponsoring the NCT03846375 clinical trial?
NCT03846375 is sponsored by Haukeland University Hospital. The principal investigator is Berge Osnes, PhD at Haukeland University Hospital. The trial plans to enroll 60 participants.